Dr. Vidhu Kariyawasam, MD

Dr. Kariyawasam practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Kariyawasam's NPI, 1134560295, was assigned on July 17, 2013. Dr. Kariyawasam graduated from Other in 2011. Dr. Kariyawasam holds Florida license ME136314.

Dr. Kariyawasam's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Kariyawasam's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kariyawasam practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Kariyawasam's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kariyawasam is board certified in infectious disease by the American Board of Internal Medicine. Dr. Kariyawasam is licensed in Florida.

Dmand AI lists cold sores or genital herpes, hiv/aids, joint or bone infection and UTI among the conditions Dr. Kariyawasam treats.

CMS data shows 574 Medicare services from Dr. Kariyawasam across 9 procedure codes in 2024, for 277 Medicare patients. Medicare paid $54,535 for them.

CMS counts 277 Medicare patients who saw Dr. Kariyawasam in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kariyawasam's median patient age at 70, with 37% women.

In 2024, Dr. Kariyawasam wrote 489 Medicare Part D claims for 72 patients. 60% of them were for generic drugs. CMS names the drug for 364 of them, across 16 drugs with 11 or more claims each, at $638,965 in total drug cost. In 2023, CMS named 406 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Kariyawasam for performance year 2024, reported through an alternative payment model (APM). Dr. Kariyawasam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kariyawasam as offering telehealth.

Dmand AI links 6 papers to Dr. Kariyawasam, published from 2019 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents. Dr. Kariyawasam has published most often in Cureus. Dr. Kariyawasam's most frequent co-authors are Kiran Motaparthi, MD, Mehmet Sait Albayram, MD and Naveen Prasath Baskaran, MD.

CMS Open Payments shows 4 general payments to Dr. Kariyawasam from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $46.

Dr. Kariyawasam graduated from Other in 2011.

Dr. Kariyawasam is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.